Talking Point: Will Pharma Remain The Dark Horse Post Covid-19?

Telecom, Pharma Remain The Worry Point Says Suhas Harinarayanan

Talking Point: Path Ahead For U.S. Generic Market And Indian Pharma Sector

Talking Point: What’s Fueling Rally In Pharma Sector? Which Pockets Could Outperform?

InCred's Aditya Khemka Talks About All Things Pharma: Talking Point

Can Pharma Sector Surprise Positively?: Aditya Khemka Answers | Talking Point

Talking Point: DSP Investment Managers' Top Picks In Pharma

Talking Point: Indian Markets To Remain Stock Specific In Near-Term?

Talking Point: Why Nilesh Shah Thinks Indian Financials Will Remain Resilient

Talking Point: Capitalising On Tech Solutions In The Post-Covid Era

Talking Point: How Aditya Narain Sees Earnings Reset Post Covid-19

Talking Point: Business Models Set To Change Post Covid-19 Pandemic

Are We In A Cyclical Uptick Post RBI Pause?: Talking Point With Hiren Ved

Buy or Sell | Remain stock specific in short term; buy ONGC, Sun Pharma

Salons, Beauty Parlours, Spa To Remain Closed; Banks, Post Offices, ATMs To Remain Open

TALKING EDGE: Catching up with Nova Pharma

Guillaume Bayre (BFM Bourse) : La pandémie rebat les cartes dans la pharma, manquant un point d'inflexion pour différentes entreprises biotechs - 02/12

Sun Pharma posts loss, Cipla gains from exports

Davos 2022 | Dr Reddy's GV Prasad On Post-Pandemic Health & Pharma Industry Opportunities

'Pharma bro' Martin Shkreli jailed after Facebook post about Hillary Clinton's hair

Does It Make Sense To Invest In Torrent Pharma & Unichem Post The Rs 3,600 Crore Deal?

Awfis Space Solutions IPO To Open May 22: Offers Co-working Spaces Nationwide | NDTV Profit

V Guard Ind Q4: Outlook On Growth | NDTV Profit

Biocon Outlook On The Biosimilar Sales | NDTV Profit

How is the Growth Wired For MSWIL? NDTV Profit

Manishi Raychaudhuri Talks Future Of Private Capex and Domestic Market Opportunities

Ideaforge's Order Book Outlook | NDTV Profit